McRae Capital Management’s Bristol-Myers Squibb BMY Stock Holding History

McRae Capital Management’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-4,953	Closed	-$317K	–	95
2023 Q2	$317K	Sell	4,953 -202,442	-98%	-$13.6M	0.09%	73
2023 Q1	$14.4M	Buy	207,395 +120	+0.1%	+$8.46K	4.14%	7
2022 Q4	$14.9M	Sell	207,275 -3,335	-2%	-$251K	4.36%	6
2022 Q3	$15M	Buy	210,610 +1,115	+0.5%	+$80.9K	4.55%	4
2022 Q2	$16.1M	Sell	209,495 -1,342	-0.6%	-$102K	4.38%	4
2022 Q1	$15.4M	Sell	210,837 -1,028	-0.5%	-$69K	3.47%	8
2021 Q4	$13.2M	Buy	211,865 +2,250	+1%	+$132K	2.76%	16
2021 Q3	$12.4M	Buy	209,615 +2,344	+1%	+$154K	2.73%	17
2021 Q2	$13.8M	Buy	207,271 +3,210	+2%	+$209K	3.17%	12
2021 Q1	$12.9M	Buy	204,061 +28,210	+16%	+$1.76M	3.19%	14
2020 Q4	$10.9M	Buy	175,851 +19,510	+12%	+$1.2M	3.13%	11
2020 Q3	$9.43M	Buy	156,341 +11,344	+8%	+$683K	3.16%	9
2020 Q2	$8.53M	Buy	144,997 +4,435	+3%	+$265K	3.19%	11
2020 Q1	$7.83M	Buy	140,562 +21,595	+18%	+$1.32M	3.82%	6
2019 Q4	$7.64M	Buy	118,967 +111,867	+1,576%	+$6.41M	2.81%	15
2019 Q3	$360K	Buy	7,100 +1,800	+34%	+$84.6K	0.14%	70
2019 Q2	$240K	Buy	+5,300	New	+$247K	0.1%	81
2018 Q2	–	Sell	-3,250	Closed	-$206K	–	99
2018 Q1	$206K	Sell	3,250 -350	-10%	-$22.5K	0.09%	88
2017 Q4	$221K	Buy	3,600 +300	+9%	+$18.8K	0.09%	88
2017 Q3	$210K	Buy	+3,300	New	+$193K	0.09%	86
2017 Q1	–	Sell	-3,540	Closed	-$207K	–	105
2016 Q4	$207K	Buy	+3,540	New	+$194K	0.09%	95
2016 Q3	–	Sell	-3,650	Closed	-$268K	–	100
2016 Q2	$268K	Hold	3,650	–	–	0.12%	83
2016 Q1	$233K	Buy	+3,650	New	+$230K	0.1%	88

Other funds holding BMY

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

McRae Capital Management's BMY Position: Q3 2023 in Review

McRae Capital Management sold out of Bristol-Myers Squibb (BMY) in Q3 2023, closing a stake of 4,953 shares — an estimated $317K sold.

McRae Capital Management first reported a position in BMY in Q1 2016 and held it in 23 quarters. The position peaked at $16.1M in Q2 2022. 2,387 funds tracked by Wall St. Rank hold BMY as of Q3 2023.

McRae Capital Management reported no remaining Bristol-Myers Squibb position as of Q3 2023 after selling out during the quarter.
McRae Capital Management sold 4,953 Bristol-Myers Squibb shares in Q3 2023, an estimated $317K.
McRae Capital Management first reported a position in Bristol-Myers Squibb in Q1 2016 and held it in 23 quarters.
McRae Capital Management's Bristol-Myers Squibb position peaked at $16.1M in Q2 2022.
2,387 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q3 2023.

Based on McRae Capital Management's 13F filing for Q3 2023, filed 17 Oct 2023.